Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 69

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Optimized serial expansion of human induced pluripotent stem cells using low-density inoculation to generate clinically relevant quantities in vertical-wheel bioreactors

Borys, Breanna S., So, Tania, Colter, James, Dang, Tiffany, Roberts, Erin L., Revay, Tamas, Larijani, Leila, Krawetz, Roman, Lewis, Ian, Argiropoulos, Bob, Rancourt, Derrick E., Jung, Sunghoon, Hashimura, Yas, Lee, Brian, Kallos, Michael S. · 2020 · Stem Cells Translational Medicine

Abstract

Human induced pluripotent stem cells (hiPSCs) have generated a great deal of attention owing to their capacity for self-renewal and differentiation into the three germ layers of the body. Their discovery has facilitated a new era in biomedicine for understanding human development, drug screening, disease modeling, and cell therapy while reducing ethical issues and risks of immune rejection associated with traditional embryonic stem cells. Bioreactor-based processes have been the method of choice for the efficient expansion and differentiation of stem cells in controlled environments. Current protocols for the expansion of hiPSCs use horizontal impeller, paddle, or rocking wave mixing method bioreactors which require large static cell culture starting populations and achieve only moderate cell fold increases. This study focused on optimizing inoculation, agitation, oxygen, and nutrient availability for the culture of hiPSCs as aggregates in single-use, low-shear, vertical-wheel bioreactors. Under optimized conditions, we achieved an expansion of more than 30-fold in 6 days using a small starting population of cells and minimal media resources throughout. Importantly, we showed that that this optimized bioreactor expansion protocol could be replicated over four serial passages resulting in a cumulative cell expansion of 1.06E6-fold in 28 days. Cells from the final day of the serial passage were of high quality, maintaining a normal karyotype, pluripotent marker staining, and the ability to form teratomas in vivo. These findings demonstrate that a vertical-wheel bioreactor-based bioprocess can provide optimal conditions for efficient, rapid generation of high-quality hiPSCs to meet the demands for clinical manufacturing of therapeutic cell products. Significance statement This study has developed a new method to grow human induced pluripotent stem cells in large quantities through serial passaging in vertical-wheel bioreactors. Cells were cultured from small starting numbers, in optimized conditions, resulting in economical, reproducible culture techniques for high-quality populations. These advances will have significant economic and practical applications in stem cell therapies.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/sctm.19-0406

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Research works printed but not linked: 40

  1. Takahashi, 2013, Induced pluripotent stem cells in medicine and biology, Development, 140, 2457, 10.1242/dev.092551 · DOI · Paper page
  2. Scudellari, 2016, How iPS cells changed the world, Nature, 534, 310, 10.1038/534310a · DOI
  3. Steiner, 2010, Derivation, propagation and controlled differentiation of human embryonic stem cells in suspension, Nat Biotechnol, 28, 361, 10.1038/nbt.1616 · DOI · Paper page
  4. Revilla, 2016, Current advances in the generation of human iPS cells: implications in cell-based regenerative medicine, J Tissue Eng Regen Med, 10, 893, 10.1002/term.2021 · DOI
  5. Liu, 2014, Stem cell engineering in bioreactors for large-scale bioprocessing, Eng Life Sci, 14, 4, 10.1002/elsc.201300013 · DOI
  6. Sart, 2017, Characterization of 3D pluripotent stem cell aggregates and the impact of their properties on bioprocessing, Process Biochem, 59, 276, 10.1016/j.procbio.2016.05.024 · DOI
  7. Guhr, 2018, Recent trends in research with human pluripotent stem cells: impact of research and use of cell lines in experimental research and clinical trials, Stem Cell Reports, 11, 485, 10.1016/j.stemcr.2018.06.012 · DOI
  8. Stoddard-Bennett, 2019, Treatment of Parkinson's disease through personalized medicine and induced pluripotent stem cells, Cells, 8, 26, 10.3390/cells8010026 · DOI
  9. Hu, 2019, Natural killer cell-based immunotherapy for cancer: advances and prospects, Engineering, 5, 106, 10.1016/j.eng.2018.11.015 · DOI
  10. Serra, 2012, Process engineering of human pluripotent stem cells for clinical application, Trends Biotechnol, 30, 350, 10.1016/j.tibtech.2012.03.003 · DOI · Paper page
  11. Reubinoff, 2000, Embryonic stem cell lines from human blastocysts: somatic differentiation in vitro, Nat Biotechnol, 18, 399, 10.1038/74447 · DOI · Paper page
  12. Richards, 2002, Human feeders support prolonged undifferentiated growth of human inner cell masses and embryonic stem cells, Nat Biotechnol, 20, 933, 10.1038/nbt726 · DOI · Paper page
  13. Rodrigues, 2011, Stem cell cultivation in bioreactors, Biotechnol Adv, 29, 815, 10.1016/j.biotechadv.2011.06.009 · DOI · Paper page
  14. Zweigerdt, 2011, Scalable expansion of human pluripotent stem cells in suspension culture, Nat Protoc, 6, 689, 10.1038/nprot.2011.318 · DOI · Paper page
  15. Olmer, 2012, Suspension culture of human pluripotent stem cells in controlled, stirred bioreactors, Tissue Eng Part C Methods, 18, 772, 10.1089/ten.tec.2011.0717 · DOI · Paper page
  16. Abbasalizadeh, 2012, Bioprocess development for mass production of size-controlled human pluripotent stem cell aggregates in stirred suspension bioreactor, Tissue Eng Part C Methods, 18, 831, 10.1089/ten.tec.2012.0161 · DOI
  17. Wang, 2013, Scalable expansion of human induced pluripotent stem cells in the defined xeno-free E8 medium under adherent and suspension culture conditions, Stem Cell Res, 11, 1103, 10.1016/j.scr.2013.07.011 · DOI
  18. Elanzew, 2015, A reproducible and versatile system for the dynamic expansion of human pluripotent stem cells in suspension, Biotechnol J, 10, 1589, 10.1002/biot.201400757 · DOI
  19. Haraguchi, 2015, Simple suspension culture system of human iPS cells maintaining their pluripotency for cardiac cell sheet engineering, J Tissue Eng Regen Med, 9, 1363, 10.1002/term.1761 · DOI
  20. Badenes, 2016, Microcarrier-based platforms for in vitro expansion and differentiation of human pluripotent stem cells in bioreactor culture systems, J Biotechnol, 234, 71, 10.1016/j.jbiotec.2016.07.023 · DOI
  21. Meng, 2017, Optimizing human induced pluripotent stem cell expansion in stirred-suspension culture, Stem Cells Dev, 26, 1804, 10.1089/scd.2017.0090 · DOI
  22. Kwok, 2018, Scalable stirred suspension culture for the generation of billions of human induced pluripotent stem cells using single-use bioreactors, J Tissue Eng Regen Med, 12, e1076, 10.1002/term.2435 · DOI
  23. Cormier, 2006, Expansion of undifferentiated murine embryonic stem cells as aggregates in suspension culture bioreactors, Tissue Eng, 12, 3233, 10.1089/ten.2006.12.3233 · DOI · Paper page
  24. Zur Nieden, 2007, Embryonic stem cells remain highly pluripotent following long term expansion as aggregates in suspension bioreactors, J Biotechnol, 129, 421, 10.1016/j.jbiotec.2007.01.006 · DOI
  25. Borys, 2019, Using computational fluid dynamics (CFD) modeling to understand murine embryonic stem cell aggregate size and pluripotency distributions in stirred suspension bioreactors, J Biotechnol, 304, 16, 10.1016/j.jbiotec.2019.08.002 · DOI
  26. Shafa, 2012, Expansion and long-term maintenance of induced pluripotent stem cells in stirred suspension bioreactors, J Tissue Eng Regen Med, 6, 462, 10.1002/term.450 · DOI
  27. Fernandes-Platzgummer, 2014, Maximizing mouse embryonic stem cell production in a stirred tank reactor by controlling dissolved oxygen concentration and continuous perfusion operation, Biochem Eng J, 82, 81, 10.1016/j.bej.2013.11.014 · DOI
  28. Croughan, 2016, Novel single-use bioreactors for scale-up of anchorage-dependent cell manufacturing for cell therapies, Stem Cell Manuf, 105, 10.1016/B978-0-444-63265-4.00005-4 · DOI
  29. Rodrigues, 2018, Scalable culture of human induced pluripotent cells on microcarriers under xeno-free conditions using single-usevertical-wheel™ bioreactors, J Chem Technol Biotechnol, 93, 3597, 10.1002/jctb.5738 · DOI
  30. Dakhore, 2018, Human pluripotent stem cell culture: current status, challenges, and advancement, Stem Cells Int, 2018, 10.1155/2018/7396905 · DOI
  31. Neofytou, 2015, Hurdles to clinical translation of human induced pluripotent stem cells, J Clin Invest, 125, 2551, 10.1172/JCI80575 · DOI · Paper page
  32. Trounson, 2016, Pluripotent stem cells progressing to the clinic, Nat Rev Mol Cell Biol, 17, 194, 10.1038/nrm.2016.10 · DOI · Paper page
  33. Ting, 2014, An intermittent rocking platform for integrated expansion and differentiation of human pluripotent stem cells to cardiomyocytes in suspended microcarrier cultures, Stem Cell Res, 13, 202, 10.1016/j.scr.2014.06.002 · DOI
  34. Davis, 2018, Automated closed-system expansion of pluripotent stem cell aggregates in a rocking-motion bioreactor, SLAS Technol, 23, 364, 10.1177/2472630318760745 · DOI
  35. Nogueira, 2019, Strategies for the expansion of human induced pluripotent stem cells as aggregates in single-useVertical-Wheel™ bioreactors, J Biol Eng, 13, 74, 10.1186/s13036-019-0204-1 · DOI
  36. Sousa, 2015, Production of oncolytic adenovirus and human mesenchymal stem cells in a single-use, Vertical-Wheel bioreactor system: impact of bioreactor design on performance of microcarrier-based cell culture processes, Biotechnol Prog, 31, 1600, 10.1002/btpr.2158 · doi:10.1002/btpr.2158
  37. Jenkins, 2015, Human pluripotent stem cell-derived products: advances towards robust, scalable and cost-effective manufacturing strategies, Biotechnol J, 10, 83, 10.1002/biot.201400348 · DOI · Paper page
  38. Otsuji, 2014, A 3D sphere culture system containing functional polymers for large-scale human pluripotent stem cell production, Stem Cell Reports, 2, 734, 10.1016/j.stemcr.2014.03.012 · DOI
  39. Borys, 2018, Scale-up of embryonic stem cell aggregate stirred suspension bioreactor culture enabled by computational fluid dynamics modeling, Biochem Eng J, 133, 157, 10.1016/j.bej.2018.02.005 · DOI
  40. Anokye-Danso, 2011, Highly efficient miRNA-mediated reprogramming of mouse and human somatic cells to pluripotency, Cell Stem Cell, 8, 376, 10.1016/j.stem.2011.03.001 · DOI · Paper page

Cited by

See all 69

Metadata

Authors
Borys, B. S., So, T., Colter, J., Dang, T., Roberts, E. L., Revay, T., Larijani, L., Krawetz, R., Lewis, I., Argiropoulos, B., Rancourt, D. E., Jung, S., Hashimura, Y., Lee, B., & Kallos, M. S.
Venue
Stem Cells Translational Medicine
Published
2020-05-22
Volume
9
Issue
9
Pages
1036-1052
ISSN
  • 2157-6564
  • 2157-6580
Cited by
69
References
4
Language
en
Funders
  • Alberta Children's Hospital Research Institute Clinical Research Fellowship
  • Vanier Canada Graduate Scholarship Program
  • Collaborative Health Research Projects
  • NSERC Discovery Grant Program

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Optimized serial expansion of human induced pluripotent stem cells using low-density inoculation to generate clinically relevant quantities in vertical-wheel bioreactors. https://app.cochat.ai/papers/10.1002/sctm.19-0406
The paper
Borys, B. S., So, T., Colter, J., Dang, T., Roberts, E. L., Revay, T., Larijani, L., Krawetz, R., Lewis, I., Argiropoulos, B., Rancourt, D. E., Jung, S., Hashimura, Y., Lee, B., & Kallos, M. S. (2020). Optimized serial expansion of human induced pluripotent stem cells using low-density inoculation to generate clinically relevant quantities in vertical-wheel bioreactors. Stem Cells Translational Medicine. https://doi.org/10.1002/sctm.19-0406

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.